Literature DB >> 7113194

Thyroid supplements: effect on bone mass.

B Ettinger, J Wingerd.   

Abstract

Thyrotoxicosis and thyroid replacement therapy can cause osteopenia. The relative effects of such therapy and of aging, body size, menopausal status and smoking on bone mass were compared by measuring the combined cortical thickness (CCT) of the second metacarpal bone in 151 women taking thyroid hormone. Age was the single factor strongly related to CCT, with the mean CCT decreasing by 0.045 mm per year. Women who had taken estrogen replacement medications had a higher CCT measurement, while those who used thyroid hormone in a dose of at least 3 grains a day had a lower CCT. The rate of loss was reduced in those women using estrogen replacement therapy and increased in those women taking 3 grains or more of thyroid hormone. Women taking 3 grains or more of thyroid hormone should be advised that they are at higher risk for osteopenia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7113194      PMCID: PMC1273943     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  13 in total

1.  THYROID THERAPY OF MYXEDEMA: A COMPARISON OF VARIOUS AGENTS WITH A NOTE ON THE COMPOSITION OF THYROID SECRETION IN MAN.

Authors:  P H LAVIETES; F H EPSTEIN
Journal:  Ann Intern Med       Date:  1964-01       Impact factor: 25.391

2.  Triiodothyronine and thyroxine content of desiccated thyroid tablets.

Authors:  R W Rees-Jones; P R Larsen
Journal:  Metabolism       Date:  1977-11       Impact factor: 8.694

3.  Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity.

Authors:  H W Daniell
Journal:  Arch Intern Med       Date:  1976-03

4.  Osteoporosis and fractures following thyrotoxicosis.

Authors:  S A Fraser; J B Anderson; D A Smith; G M Wilson
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

5.  Osteoporosis in thyrotoxicosis.

Authors:  D G Ikkos; P Katsichtis; K Ntalles; C Velentzas
Journal:  Lancet       Date:  1971-11-20       Impact factor: 79.321

6.  Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation.

Authors:  J M Stock; M I Surks; J H Oppenheimer
Journal:  N Engl J Med       Date:  1974-03-07       Impact factor: 91.245

7.  Comparison of microradioscopic and morphometric findings in the hand bones with densitometric findings in the proximal radius in thyrotoxicosis and in renal osteodystrophy.

Authors:  H E Meema; S Meema
Journal:  Invest Radiol       Date:  1972 Mar-Apr       Impact factor: 6.016

8.  Prevention of spinal osteoporosis in oophorectomised women.

Authors:  R Lindsay; D M Hart; C Forrest; C Baird
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

9.  Preventive effect of estrogen on postmenopausal bone loss.

Authors:  S Meema; M L Bunker; H E Meema
Journal:  Arch Intern Med       Date:  1975-11

10.  Detecting unsuspected thyroid dysfunction by the free thyroxine index.

Authors:  L V dos Remedios; P M Weber; R Feldman; D A Schurr; T G Tsoi
Journal:  Arch Intern Med       Date:  1980-08
View more
  3 in total

1.  Post-menopausal Osteoporosis: Can it Be Prevented?

Authors:  J P Wade; E F Vreede-Brown
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

2.  Increasing age-adjusted risk of fragility fractures: a sign of increasing osteoporosis in successive generations?

Authors:  K J Obrant; U Bengnér; O Johnell; B E Nilsson; I Sernbo
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

3.  Risks Associated with Treating Hypothyroidism: Potential hazards of L-thyroxine therapy.

Authors:  H C Gerstein
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.